|19th January 2021||John F Sullivan||9,617||Open or private sale||$22.12||$212,728.04|
|19th January 2021||John F Sullivan||9,617||Exercise of derivative||$0.39||$3,750.63|
|4th January 2021||Stephen Gordon||1,184||Open or private sale||$20.00||$23,680.00|
|31st December 2020||Stephen Gordon||8,816||Open or private sale||$20.00||$176,320.00|
|21st December 2020||John F Sullivan||1,000||Open or private sale||$17.99||$17,990.00|
|16th December 2020||John F Sullivan||1,000||Exercise of derivative||$0.39||$390.00|
|15th December 2020||John F Sullivan||3,000||Exercise of derivative||$0.39||$1,170.00|
|15th December 2020||John F Sullivan||3,000||Open or private sale||$16.63||$49,890.00|
|11th December 2020||Miriam Provost||4,600||Exercise of derivative||$3.22||$14,812.00|
|23rd November 2020||Ventures Fund Iv General Partner Llc Flagship||3,587,820||Other acquisition or disposition||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
TransMedics Group, Inc. focuses on the preservation of human organs for transplant in a near-physiologic condition. The company was founded by Waleed H. Hassanein in October 2018.